語系/ Language:
繁體中文
English
KMU OLIS
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
DNA methylation and complex human di...
~
Neidhart, Michel.
DNA methylation and complex human disease
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
DNA methylation and complex human disease/ Michel Neidhart.
作者:
Neidhart, Michel.
出版者:
San Diego, CA :Academic Press, : c2015.,
面頁冊數:
1 online resource (xv, 529 p.) :ill. :
提要註:
Reviews the possibilities of methyl-group-based epigeneticbiomarkers of major diseases, tailored epigenetic therapies, and the future uses of high-throughput methylome technologies. this volume includes many pertinent advances in disease-bearing research, including therapies and the possibility of using methyl donors. DNA methylation is also discussed as a plasma and serum test for non-invasive screening, diagnostic and prognostic tests, as compared to biopsy-driven gene expression analysis. The author also presents the importance of high-throughput methylome analysis, as well as the advantages of DNA methylation as a biomarker over other molecular processes. An excellent resource for basic biology and translational researchers interested in developmental biology, genetics health genomics, epigenesis in complex disease, and therapeutic possibilities. Developmental biologists, geneticists, biotechnologists, and epidemiologists also have much to gain from this specialized and focused volume.
標題:
DNA - Methylation. -
電子資源:
click for full text
ISBN:
9780124201941 (electronic bk.)
DNA methylation and complex human disease
Neidhart, Michel.
DNA methylation and complex human disease
[electronic resource] /Michel Neidhart. - San Diego, CA :Academic Press,c2015. - 1 online resource (xv, 529 p.) :ill.
Includes bibliographical references and index.
DNA methylation : introduction -- DNA methylation and epigenetic biomarkers in cancer -- DNA methylation and epigenetic biomarkers in non-neoplastic diseases -- DNA methylation and environmental factors -- DNA methylation and epidemiology -- DNA methylation and viral infections -- DNA methylation and cancer -- DNA methylation in breast and ovarian carcinomas -- DNA methylation in acquired drugresistance -- DNA methylation and endocrinology -- DNA methylation in metabolic diseases -- DNA methylation in pituitary diseases -- DNA methylation and development -- DNA methylation in growth retardation -- DNA methylation in cardiology -- DNA methylation and neurology -- DNA methylation in psychiatric diseases -- DNA methylation in cellular mechanisms of neurodegeneration -- DNA methylation and autoimmunity -- DNA methylation in lymphocyte development -- DNA methylation in stem cell diseases -- DNA methylation and rheumatology -- DNA methylation in synovial fibroblasts -- DNA methylation in osteoporosis -- Epigenetic therapies -- Demethylating agents -- Methyl donors -- Methylome analysis of complex diseases -- Methylome analysis in cancer -- Methylome analysis in non-neoplastic disease -- Outlook.
Reviews the possibilities of methyl-group-based epigeneticbiomarkers of major diseases, tailored epigenetic therapies, and the future uses of high-throughput methylome technologies. this volume includes many pertinent advances in disease-bearing research, including therapies and the possibility of using methyl donors. DNA methylation is also discussed as a plasma and serum test for non-invasive screening, diagnostic and prognostic tests, as compared to biopsy-driven gene expression analysis. The author also presents the importance of high-throughput methylome analysis, as well as the advantages of DNA methylation as a biomarker over other molecular processes. An excellent resource for basic biology and translational researchers interested in developmental biology, genetics health genomics, epigenesis in complex disease, and therapeutic possibilities. Developmental biologists, geneticists, biotechnologists, and epidemiologists also have much to gain from this specialized and focused volume.
ISBN: 9780124201941 (electronic bk.)Subjects--Topical Terms:
413434
DNA
--Methylation.
LC Class. No.: QP624.5.M46 / N45 2016
Dewey Class. No.: 572.8/6
DNA methylation and complex human disease
LDR
:03106nam a2200265 a 4500
001
301556
003
OCoLC
005
20151105110008.0
006
m o d
007
cr cn|||||||||
008
170113s2015 caua ob 001 0 eng
020
$a
9780124201941 (electronic bk.)
020
$a
0124201946 (electronic bk.)
035
$a
(OCoLC)885228983
$z
(OCoLC)885225067
035
$a
16000412
040
$a
BTCTA
$b
eng
$c
BTCTA
$d
YDXCP
$d
UKMGB
$d
CDX
$d
OBE
$d
CBY
$d
WSU
041
0
$a
eng
050
4
$a
QP624.5.M46
$b
N45 2016
082
0 4
$a
572.8/6
$2
23
100
1
$a
Neidhart, Michel.
$3
413433
245
1 0
$a
DNA methylation and complex human disease
$h
[electronic resource] /
$c
Michel Neidhart.
260
$a
San Diego, CA :
$b
Academic Press,
$c
c2015.
300
$a
1 online resource (xv, 529 p.) :
$b
ill.
504
$a
Includes bibliographical references and index.
505
0
$a
DNA methylation : introduction -- DNA methylation and epigenetic biomarkers in cancer -- DNA methylation and epigenetic biomarkers in non-neoplastic diseases -- DNA methylation and environmental factors -- DNA methylation and epidemiology -- DNA methylation and viral infections -- DNA methylation and cancer -- DNA methylation in breast and ovarian carcinomas -- DNA methylation in acquired drugresistance -- DNA methylation and endocrinology -- DNA methylation in metabolic diseases -- DNA methylation in pituitary diseases -- DNA methylation and development -- DNA methylation in growth retardation -- DNA methylation in cardiology -- DNA methylation and neurology -- DNA methylation in psychiatric diseases -- DNA methylation in cellular mechanisms of neurodegeneration -- DNA methylation and autoimmunity -- DNA methylation in lymphocyte development -- DNA methylation in stem cell diseases -- DNA methylation and rheumatology -- DNA methylation in synovial fibroblasts -- DNA methylation in osteoporosis -- Epigenetic therapies -- Demethylating agents -- Methyl donors -- Methylome analysis of complex diseases -- Methylome analysis in cancer -- Methylome analysis in non-neoplastic disease -- Outlook.
520
$a
Reviews the possibilities of methyl-group-based epigeneticbiomarkers of major diseases, tailored epigenetic therapies, and the future uses of high-throughput methylome technologies. this volume includes many pertinent advances in disease-bearing research, including therapies and the possibility of using methyl donors. DNA methylation is also discussed as a plasma and serum test for non-invasive screening, diagnostic and prognostic tests, as compared to biopsy-driven gene expression analysis. The author also presents the importance of high-throughput methylome analysis, as well as the advantages of DNA methylation as a biomarker over other molecular processes. An excellent resource for basic biology and translational researchers interested in developmental biology, genetics health genomics, epigenesis in complex disease, and therapeutic possibilities. Developmental biologists, geneticists, biotechnologists, and epidemiologists also have much to gain from this specialized and focused volume.
650
0
$a
DNA
$x
Methylation.
$3
413434
650
0
$2
96060
$a
Medical genetics.
$3
240938
650
2
$a
DNA Methylation.
$3
413435
856
4 0
$u
http://www.sciencedirect.com/science/book/9780124201941
$z
click for full text
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得,請勿在此評論區張貼涉及人身攻擊、情緒謾罵、或內容涉及非法的不當言論,館方有權利刪除任何違反評論規則之發言,情節嚴重者一律停權,以維護所有讀者的自由言論空間。
Export
取書館別
處理中
...
變更密碼
登入